Navigation Links
XTENT Announces First Quarter 2008 Financial Results
Date:4/28/2008

ext month in Barcelona, Spain."

CUSTOM III Long and Multi-lesion Trial Six-Month Data To Be Presented At EuroPCR

Six-month follow-up data from the CUSTOM III clinical trial will be presented at the annual EuroPCR meeting, taking place May 13 through 16 in Barcelona, Spain. The company will exhibit as well as host a symposium on customizable drug-eluting stents.

Schedule of XTENT Events for EuroPCR

Tuesday, May 13, 2008, 3:30-6:30 p.m. CEST

Late-Breaking Clinical Trial: CUSTOM III trial 6-month follow-up results. Bernard de Bruyne, M.D., Ph.D., Cardiovascular Center, OLV Hospital in Aalst, Belgium, the principal investigator of the CUSTOM III clinical trial, will present six-month follow-up data from the CUSTOM III trial evaluating use of the Custom NX(R) Drug Eluting Stent (DES) System in patients with long or multiple coronary lesions.

Wednesday, May 14, 2008, 5:00-6:30 p.m. CEST

Evening symposium: Customizable drug-eluting stents: a breakthrough approach to the percutaneous treatment of coronary artery disease.

The symposium will provide an overview of the Custom NX DES System with respect to the treatment of long and multi-lesion coronary artery disease, and the CUSTOM clinical program.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to customize the length and diameter of the stent at the site of the lesion. The system features a proprietary modular stent design that consists of multiple 6mm cobalt chromium segments coated with Biolimus A9(R) and PLA, a biodegradable drug carrier. The Custom NX delivery system enables separation at each 6mm segment and allows for the placement of up to 60mm of stent.

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... Chief Executive Officer, has been elected to the Company,s ... Steven G. Anderson , Executive Chairman of CryoLife, stated, ... to be an excellent leader who is well positioned ...
(Date:10/22/2014)... JERUSALEM , October 22, 2014 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused ... today reported positive top-line clinical results from its ... proprietary oral insulin capsules, to treat type 1 ... United States under a U.S. Food ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms of ... or unnoticed, but new technology, coupled with yearly, ... leading to earlier detection of eye diseases, including ... million Americans. If left untreated, these diseases can ... Recently, optometric researchers have deployed ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
...  Global performance improvement solutions provider General Physics Corporation ... (NYSE: GPX ), today announced that its ... Award for Excellence in Marketing and Communications in the ... http://photos.prnewswire.com/prnh/20110404/MM77341LOGO-b ) The MarCom Awards is ...
... SAN FRANCISCO, Dec. 8, 2011 ClinStar, LLC , ... markets of Russia and Eastern Europe to the biopharmaceutical industry, ... Minutes series by Business Day TV hosted by Terry Bradshaw.  ... 10 to 15 years and over one billion dollars to launch ...
Cached Medicine Technology:GP's PerformTech Division Receives Prestigious MarCom Award 2GP's PerformTech Division Receives Prestigious MarCom Award 3ClinStar to Be Featured on Business Day TV With Terry Bradshaw 2
(Date:10/25/2014)... home safe and sound is one of the best Halloween ... costumes and goody bags have reflective strips that improve visibility ... at Meadowlands Hospital Medical Center in Secaucus, N.J. ... flame-resistant, Davis said. He offers these others tips: ... a small area of skin first to ensure it doesn,t ...
(Date:10/25/2014)... October 25, 2014 The ... which verifies IT-accessibility for disabled users by disabled ... logo to Mackin Educational Resources of Burnsville, ... management system and to the Minnesota Alliance for ... "Own Best Medicine" website. Both organizations ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
(Date:10/25/2014)... Oct. 23, 2014 (HealthDay News) -- Current osteoporosis ... younger postmenopausal women at risk for osteoporosis-related fractures, ... to prevent fractures, we need tools that help ... injuries so that we can target these at-risk ... Crandall, professor of medicine in the division of ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
... Diabetic retinopathy is the most common disorder seen in diabetics. ... a person with diabetes develops diabetic retinopathy,// a major cause ... diabetes is responsible for 7 percent of legal blindness, making ... adults 22 to 70 years old. ,Researchers from the ...
... can block the death of brain cells in mice who ... (HD), which is a rare degenerative brain disorder //caused by ... may be one step closer to a treatment, according to ... treated with a bile acid known as tauroursodeoxycholic acid (TUDCA), ...
... shows people with diabetes who are in a happy ... unhappily married counterparts. Researchers from the State University of ... adults with diabetes who had been married for an ... insulin, were surveyed again two years after the initial ...
... the University in Boston, a person's degree of inhibition when ... tied to his or her likelihood of being overweight. The ... low-calorie foods--can help people who just can't seem to resist ... B. Roberts. The reasons why some people are able to ...
... According to a new study, it has been found ... as you age. Mental decline is not a specific part ... are typically living longer. The ability to know, think, learn ... of life and survival in older ages. Researchers from the ...
... cancer all over the world. More than 30,000 women ... breast cancer this year. Researchers now believe small family ... fueling this ever-growing epidemic.// ,Researchers from England ... information on breastfeeding and childbearing patterns. Together, the studies ...
Cached Medicine News:Health News:Stop and think before you eat 2Health News: Breastfeeding may decrease Breast Cancer Risk 2
The ultimate replacement device, the Contour MD ICD offers a maximum stored energy of 42 J. The device delivers high-energy defibrillation output and is ideal for patients with maximum energy defibri...
... a key participant in the area of ... decade. Previous Medtronic autotransfusion systems allowed clinicians ... well as to determine requirements for a ... (PRP) for a small amount of autologous ...
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0...
... catheters comprise the world's broadest line ... procedures. Their advanced catheter design and ... response with a soft, atraumatic tip. ... sizes, Supreme and Response catheters provide ...
Medicine Products: